Sally Uppal

Bachelor of Medicine and Bachelor of Science,  Massachusetts General Hospital 

Location: India

Consulting Services

Admin and Customer Support Scientific Writing Research Consulting Journal Manuscript Legal Support

Areas Of Interest

Mass Spectrometry-Mass Spectrometry Diabetic Neuropathies, Painful Cytochrome P450 Family 7 Tamsulosin Hydrochloride TTase-1 SKF525A Surface Mapping, Body Cyclobutane Dimer, Thymine-Thymine Sudek's Atrophy Patched Homolog 2 Drug Prescriptions worm, Eisenia Disease, Sandhoff-Jatzkewitz-Pilz Large Neutral Amino Acid Transporter 1 Atrophies, Hemifacial Radioisotopes, Nitrogen Nyctereutes procyonoides Cephalotaxus Alkaloids Transcription Factor, E2F3a Reactive Arthritis Zona Occludens 2 Protein Metalloproteinase, MMP13 Autoimmune Myositis, Experimental Activated Coagulation Time, Whole Blood Membranes, Intracellular Salicylic Acids, 6-Alkyl Tricuspid Valve Atresias Prosthesis Design, Dental Diamine Oxidase, Xylylene Propionicacidemia Disorders, Phosphorus Metabolism Firefly Luciferin Lown-Ganong-Levine Syndrome Pepper, Jaborandi

Professional Narrative

Dr. Sally Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Senior Director, Amgen 2017
Assistant Professor, Mayo Clinic 2019

Education

Doctor of osteopathic medicine, Yale School of Medicine 1998
Doctor of medicine, Harvard Medical School 2005

Referees


Publications

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :